Clinical Trial Update: Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating imatinib (Glivec) in combination with m-FOLFOX and bevacizumab (Avastin) for advanced colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Glivec (imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Colorectal Cancer | Phase 1 | Status: TERMINATED